Thomas W. Concannon

Photo of Thomas Concannon
Senior Policy Researcher
Boston Office


Ph.D. in health policy and administration, Harvard University; M.A. in political science, McGill University; B.A. in political science, University of Massachusetts

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email

More Experts


Thomas Concannon is a senior policy researcher at the RAND Corporation, assistant professor of medicine at Tufts University School of Medicine (2006–present), and Codirector of Stakeholder and Community Engagement at Tufts Clinical and Translational Science Institute (2015–present). For more than 25 years, Concannon has collaborated with patients, clinicians, and other stakeholders in health care and research. Concannon pursues two major research interests: (1) delivery, access, and use of specialty care, including in burns, cardiovascular, and orthopedic health services, (2) involvement of patients, clinicians, and other stakeholders in clinical and translational science. He is committed to improving the usefulness of research in policy decisions. He leads several large evaluations of PCORI, CMS, CMMI, and CDC programs and service delivery models. He has published frameworks aimed at improving the translation of biomedical research through pragmatic and stakeholder-engaged study. 

Concannon earned his Ph.D. in health policy at Harvard University and his M.A. in political science at McGill University.

Concurrent Non-RAND Positions

Assistant Professor, Tufts University School of Medicine; Co-Director, Stakeholder and Community Engagement Program, Tufts Clinical and Translational Sciences Institute

Previous Positions

Staff Consultant, John Snow, Inc., Boston, Massachusetts; Client Services Director, North Shore AIDS Health Project, Gloucester, Massachusetts

Recent Projects

  • Engagement Measures Landscape Analysis
  • Evaluation of Million Hearts Model (MHM)
  • Translational Impact of the World Trade Center Health Research Program
  • Tufts Clinical and Translational Science Institute (National Center for Advancing Translational Science - Stakeholder and Community Engagement
  • Assessment of Appropriate Use of Real-World Evidence for Medical Devices

Selected Publications

Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK, "A new taxonomy for stakeholder engagement in patient centered outcomes research," Journal of General Internal Medicine, 27(8), 2012

Concannon TW, Friedberg MW, Hwang A, Wiitala K, , Engaging Consumers in the Quality Measurement Enterprise. , RAND Corporation (RR-1760), 2017

Concannon TW, Grant S, Welch V, Petkovic J, Selby J, Crowe S, Synnot A, Greer-Smith R, Mayo-Wilson E, Tambor E, Tugwell P, for the Multi-Stakeholder Engagement (MuSE) Consortium, "Practical guidance for involving stakeholders in health research," Journal of General Internal Medicine, 34(3), 2019

Concannon TW "Engaging Patients and Stakeholders in Health Research: An Introduction," in Zimmerman, EB, Researching health together: Engaging patients and stakeholders in health research from topic identification to policy change, SAGE Publishing, 2020

Concannon TW, Stem K, Chaplin J, Girman CJ "Stakeholder Engagement in the Design and Conduct of Pragmatic Randomized Trials," in Girman CJ, Ritchey ME , Pragmatic Randomized Clinical Trials Using Primary Data Collection and Electronic Health Records, Elsevier, 2021

Timbie JW, Kim AY, Concannon TW, "Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment," Value in Health, 24(12), 2021

Concannon TW., Faherty LJ, Madrigano J, Mann S, Chari R, Siddiqi SM, Lee J, Hiatt L, Translational Impacts of World Trade Center Health Program Research: A Mixed Methods Study. , RAND Corporation (RR-A390-1), 2021

Lerner D, Palm ME, Concannon TW , Broadly Engaged Team Science in Clinical and Translational Science, Springer, 2022

Honors & Awards

  • PhRMA Foundation Challenge Award (first place, $50,000) for Frank L, Concannon TW. Here to Represent: Optimizing Representativeness and Enhancing Equity Through Patient-Engaged Healthcare Valuation in American Journal of Managed Care. Supplement published, PhRMA Foundation


German, English


  • Patients in the hallway as St. Mary Medical Center during the outbreak of the COVID-19 in Apple Valley, California, January 12, 2021, photo by Mike Blake/Reuters

    Who Gets Care When Hospitals Are Overwhelmed? Clear Policies Are Often Lacking

    As COVID-19 cases and hospitalizations surge to new highs, states, health systems, and the public continue to need clarity on health care resource allocation policy. A RAND checklist provides clear and consistent criteria for structuring such difficult decisions.

    Jan 21, 2021 The RAND Blog

  • Closeup of hands of a Black doctor shaking hands with a white patient, photo by LumiNola/Getty Images

    Patients Should Have a Role in Deciding the Value of Medicines

    Patients, their family members, and the general public have historically been excluded from contributing to health care value assessment models. But methods for including patient voices in research are far less complicated or demanding than some researchers believe they will be.

    Jul 10, 2020 STAT

  • A doctor sitting at a desk, using a laptop

    What Makes Stakeholders Want to Become Involved in Research?

    Involving stakeholders in comparative-effectiveness research is important. But competing demands for their time can make this a challenge. Why do stakeholders get involved in this research, or not?

    May 2, 2016 The RAND Blog

  • Medical professionals discussing research

    What Do Stakeholders Say About Comparative-Effectiveness Research?

    Insurers, employers, and industry are some of the stakeholder groups that are critical to the success of comparative-effectiveness research. Current research models may not provide stakeholders with all the information they need to support their involvement.

    Apr 25, 2016 The RAND Blog

  • Medical staff helping senior woman walk with a walker

    More Research Is Needed on Artificial Joints and Patients Can Play a Key Role

    Safety problems with artificial knees and hips, including product recalls, highlight the need for more patient-centered research. RAND has partnered with CreakyJoints in a project intended to train a group of patients to get involved in research on this topic.

    Jan 22, 2016 Bloomer Boomer

  • A doctor explaining something on a tablet to her patient

    Can Patient-Centered Outcomes Research Improve Health Care?

    A review in 2017 of the adequacy and use of Patient-Centered Outcomes Research Trust Funds will be used to determine whether funding levels should be continued or adjusted after its authorization runs out in 2019. Researchers ought to take stock of the work in patient-centered outcomes research.

    Jul 31, 2015 The BMJ